http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Reid Colposcopic Index Evaluation: Comparison of General and Oncologic Gynecologists
Aue-Aungkul, Apiwat,Suprasert, Prapaporn Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.12
The Reid colposcopic index (RCI) helps physicians for interpret the results of colposcopic examination. To compare the accuracy of RCI in colposcopic evaluation between general and oncologic gynecologists, this prospective trial was conducted by invited women over 20 years of age who were scheduled for a colposcopy at Chiang Mai University Hospital between August, 2008 and May, 2014 to participate. Pregnant patients or those having a history of hysterectomy or conization were excluded. During the colposcopy, all patients were simultaneously evaluated by general and oncologic gynecologists utilizing the RCI. Further management with either a biopsy or LEEP in each patient was dependent on the decision of the attending oncologic gynecologist. The accuracy of the RCI in diagnosing HSIL or more was calculated by the comparison with the final histology. Finally, 135 patients were recruited into this study. The sensitivity, specificity, PPV, NPV, and accuracy of RCI in diagnosing HSIL or more in general gynecologists were 45.2%, 80.7%, 41.1%, 83.2% and 72.6% while in the oncologic gynecologists were 51.6%, 85.6%, 51.6%, 85.6% and 77.8%, respectively. The difference in accuracy between evaluator groups was not significant (p-value=0.28). Of 3 patients with invasive cervical cancer, all were undetected by the general gynecologists using RCI while only 1 invasive cervical cancer was missed via RCI by the oncologic gynecologists. We conclude that RCI could be used by general gynecologists in provincial hospitals with major concerns about missing invasive cervical cancer. A short training period regarding colposcopy might help to resolve this problem.
Suprasert, Prapaporn,Aue-Aungkul, Apiwat,Pautad, Nuthaya Asian Pacific Journal of Cancer Prevention 2016 Asian Pacific journal of cancer prevention Vol.17 No.3
Egg white intake during chemotherapy is common advice for cancer patients for the prevention of leukopenia. However, the benefit is uncertain. We conducted this prospective study to identify the relationship of egg white intake for gynecologic cancer patients who received carboplatin and paclitaxel and the occurrence of leukopenia. Between January 2014 and January, 2015, 81 patients were interviewed regarding their intake of egg whites before receiving subsequent chemotherapy. The basic data, the details of egg white intake and the grade of leukopenia in the previous cycle were recorded. The mean age was 54.1 years and 80% of the patients had a diagnosis of ovarian or endometrial cancer. The patients were interviewed at cycles 1-3 in 45 cases, 4-6 in 45 cases and 7-9 in two cases. Subsequent dose reduction was found in 6.2% and granulocyte-stimulating growth factors was given at 4.9%. All the patients ate egg whites with variations in the number of eggs per day as follows: less than one (3), one to two (56), three to four (14) and five to six (8). Over 70% were recommended by nurses to eat egg whites and about 63% of patients received other supplemental food. Some 44.1% of the patients who ate less than or equal to two eggs per day and 36.4% who ate more than two eggs per day developed grade 2-4 leukopenia, P = 0.61. In conclusion, the data did not provide evidence in support of the conclusion that a greater egg white intake could significantly reduce the occurrence of leukopenia.
Thamawoot Phoblap,Amornrat Temtanakitpaisan,Apiwat Aue-angkul,Pilaiwan Kleebkaow,Bandit Chumworathayi,Sanguanchoke Luanratanakorn,Yuwadee Itarat 대한산부인과학회 2022 Obstetrics & Gynecology Science Vol.65 No.5
ObjectiveTo evaluate the performance of “Smartscopy” in diagnosing preinvasive cervical lesions among patients withabnormal cervical cancer screening results obtained during the coronavirus disease 2019 (COVID-19) pandemic. MethodsThis diagnostic study enrolled non-pregnant women with abnormal cervical cancer screening results obtained atthe colposcopy clinic at Srinagarind Hospital (Khon Kaen, Thailand) between September 2020 and March 2021. Twocolposcopists independently evaluated the uterine cervix using a smartphone and colposcopy. Cervical biopsies andendocervical curettage were performed in accordance with standard procedures. The diagnostic performance of asmartphone in detecting low-grade squamous intraepithelial lesions or worse plus (LSIL+) and high-grade squamousintraepithelial lesions plus (HSIL+) was assessed. ResultsIn total, 247 patients were included. There was high agreement between the two colposcopists (κ=0.88; 95%confidence interval [CI], 0.82-0.93). The sensitivity, specificity, positive predictive value, negative predictive value, andaccuracy of the smartphone to detect LSIL+ were 96.6% (95% CI, 91.6-99.1), 12.9% (95% CI, 8.06-19.2), 46.2% (95%CI, 39.7-52.4), 83.3% (95% CI, 62.6-95.3), and 0.49% (95% CI, 0.43-0.55), respectively. The sensitivity, specificity, positivepredictive value, negative predictive value, and accuracy of smartscopy in diagnosing HSIL+ were 67.6% (95% CI, 55.2-78.5), 85.4% (95% CI, 79.9-90.0), 60.5% (95% CI, 48.6-71.6), 88.9% (95% CI, 83.7-92.9), and 81.0% (95% CI, 0.75-0.85),respectively. ConclusionSmartscopy demonstrated a remarkable correlation with colposcopy and a high diagnostic performance value for thedetection of preinvasive cervical lesions. Therefore, smartscopy may be an alternative tool for detecting abnormalcervical lesions in low to medium medical resource settings. Smartscopy may be applied in telemedicine during theCOVID-19 pandemic.
Panarat Orachum,Amornrat Temtanakitpaisan,Pilaiwan Kleebkaow,Bandit Chumworathayi,Sanguanchoke Luanratanakorn,Apiwat Aue-angkul,Yuwadee Itarat 대한산부인과학회 2022 Obstetrics & Gynecology Science Vol.65 No.5
ObjectiveTo investigate the prevalence of p53 mutations and associated factors between immunohistochemistry (IHC) and p53staining patterns among patients with high-grade serous ovarian carcinoma (HGSOC). MethodsThis study is a retrospective review. A total of 62 patients with HGSOC underwent surgery at Srinagarind Hospitalbetween January 2016 and December 2020. Histological examination was performed based on a combination ofmorphology and IHC staining with p53. The p53 immunostaining pattern was interpreted as a missense mutation,nonsense mutation, or a wild-type pattern. Missense (p53 overexpression pattern) and nonsense (null expression p53pattern) mutations were considered p53 mutations. A wild-type pattern was defined as a p53 non-mutation. Resultsp53 mutations were identified in 93.6% of the patients. Subgroup analysis of the p53 mutation group betweenthe p53 overexpression pattern and the p53 null expression pattern in terms of clinicopathological characteristicsand initial treatment was performed. Patients with the p53 overexpression pattern had significantly more omentalmetastases than those with the p53 null expression pattern (87.8% vs. 64.7%, P=0.042). There were no statisticallysignificant differences in median progression-free survival (PFS) (9 vs. 10 months, P=0.813) or median overall survival(OS) (12 vs. 17 months, P=0.526) between the two groups. ConclusionThe prevalence of p53 mutations in HGSOC patients in this study was 93.6%. Omental metastasis is a significantpathological factor in predicting overexpression p53 pattern in HGSC. However, IHC analysis of the p53 stainingpattern did not affect OS or PFS among patients with HGSOC.
Measurement oftt¯spin correlation inpp¯collisions using the CDF II detector at the Tevatron
Aaltonen, T.,Á,lvarez Gonzá,lez, B.,Amerio, S.,Amidei, D.,Anastassov, A.,Annovi, A.,Antos, J.,Apollinari, G.,Appel, J. A.,Apresyan, A.,Arisawa, T.,Artikov, A.,Asaadi, J.,Ashmanskas, W.,Aue American Physical Society 2011 PHYSICAL REVIEW D - Vol.83 No.3
Search for Randall-Sundrum gravitons in the diphoton channel at CDF
Aaltonen, T.,Á,lvarez Gonzá,lez, B.,Amerio, S.,Amidei, D.,Anastassov, A.,Annovi, A.,Antos, J.,Apollinari, G.,Appel, J. A.,Apresyan, A.,Arisawa, T.,Artikov, A.,Asaadi, J.,Ashmanskas, W.,Aue American Physical Society 2011 PHYSICAL REVIEW D - Vol.83 No.1
Search for the Higgs boson in the all-hadronic final state using the full CDF data set
Aaltonen, T.,Gonzá,lez, B. Á,lvarez,Amerio, S.,Amidei, D.,Anastassov, A.,Annovi, A.,Antos, J.,Apollinari, G.,Appel, J. A.,Apresyan, A.,Arisawa, T.,Artikov, A.,Asaadi, J.,Ashmanskas, W.,Aue Springer-Verlag 2013 Journal of high energy physics Vol.2013 No.2
Aaltonen, T.,Á,lvarez Gonzá,lez, B.,Amerio, S.,Amidei, D.,Anastassov, A.,Annovi, A.,Antos, J.,Apollinari, G.,Appel, J. A.,Apresyan, A.,Arisawa, T.,Artikov, A.,Asaadi, J.,Ashmanskas, W.,Aue American Physical Society 2010 Physical Review Letters Vol.105 No.25
<P>A precision measurement of the top quark mass m_{t} is obtained using a sample of tt[over ¯] events from pp[over ¯] collisions at the Fermilab Tevatron with the CDF II detector. Selected events require an electron or muon, large missing transverse energy, and exactly four high-energy jets, at least one of which is tagged as coming from a b quark. A likelihood is calculated using a matrix element method with quasi-Monte Carlo integration taking into account finite detector resolution and jet mass effects. The event likelihood is a function of m_{t} and a parameter ?_{JES} used to calibrate the jet energy scale in situ. Using a total of 1087 events in 5.6??fb^{-1} of integrated luminosity, a value of m_{t}=173.0±1.2??GeV/c^{2} is measured.</P>